Sign in
Active, not recruitingNo phase

Immune Resolution After Staphylococcus Aureus Bacteremia

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
102 people enrolled
Started
Jun 2013
Expected to end
Jun 2027
Type of study
Observational, 2 groups
Record updated
13 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • At least one blood culture positive for S. aureus
  • Patients aged ≥18 years
  • At least two of four systemic inflammatory response syndrome (SIRS) criteria on the day of positive blood cultures. SIRS criteria are:; Body temperature less than 36°C(96.8°F) or greater than 38°C(100.4°F); Heart rate greater than 90 beats per minute; Tachypnea (high respiratory rate), with greater than 20 breaths per minute; or, an arterial partial pressure of carbon dioxide less than 32 mmHg; WBC less than 4000 cells/mm³ (4 x 109 cells/L) or greater than 12,000 cells/mm³ (12 x 109 cells/L); or the presence of greater than 10% immature neutrophils (band forms)

Who cannot take part

  • Sequential Organ Failure Assessment (SOFA) score > 12 on day of positive blood cultures
  • Survival expected to be < 7 days from positive blood cultures

Where in United States

  • University of Chicago HospitalChicago, United States

About the trial

What the trial wants to find out

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune function change with time in patients with and without prior immune dysfunction who survive sepsis from Staphylococcus aureus bacteremia.

Read full original descriptionShow less

We hypothesize that patients with prior immune dysfunction will have greater reductions in HLA-DR and other markers of immune function after an episode of sepsis than people who do not have prior immune dysfunction.

The 2 groups in the trial

  • Immunosuppressed

    Immunosuppressed includes patients with any one of the following: 1. a diagnosis of a hematological malignancy 2. a diagnosis of HIV 3. myelosuppressive chemotherapy in the previous 90 days 4. immune-modulating medications in the previous 90 days

  • Non-Immunosuppressed

    Subject does not fit immunosuppressed criteria

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
13 July 2026